Integrated BioPharma Statistics
Total Valuation
INBP has a market cap or net worth of $6.47 million. The enterprise value is $8.01 million.
| Market Cap | 6.47M |
| Enterprise Value | 8.01M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
INBP has 30.10 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Shares Outstanding | 30.10M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 79.76% |
| Owned by Institutions (%) | 0.07% |
| Float | 9.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| Forward PS | n/a |
| PB Ratio | 0.35 |
| P/FCF Ratio | 25.95 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 32.13 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.93 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.12 |
| Interest Coverage | 29.46 |
Financial Efficiency
Return on equity (ROE) is -2.07% and return on invested capital (ROIC) is -3.28%.
| Return on Equity (ROE) | -2.07% |
| Return on Assets (ROA) | -1.50% |
| Return on Capital (ROIC) | -3.28% |
| Revenue Per Employee | $443,965 |
| Profits Per Employee | -$2,730 |
| Employee Count | 141 |
| Asset Turnover | 2.38 |
| Inventory Turnover | 5.29 |
Taxes
In the past 12 months, INBP has paid $16,000 in taxes.
| Income Tax | 16,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.67% in the last 52 weeks. The beta is 0.51, so INBP's price volatility has been lower than the market average.
| Beta (1Y) | 0.51 |
| 52-Week Price Change | -42.67% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 46.48 |
| Average Volume (30 Days) | 3,332 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | 11,751 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, INBP had revenue of $62.60 million and -$385,000 in losses. Loss per share was -$0.01.
| Revenue | 62.60M |
| Gross Profit | 3.35M |
| Operating Income | -683,000 |
| Pretax Income | -369,000 |
| Net Income | -385,000 |
| EBITDA | -78,000 |
| EBIT | -677,600 |
| Loss Per Share | -$0.01 |
Balance Sheet
The company has $732,000 in cash and $2.27 million in debt, giving a net cash position of -$1.54 million or -$0.05 per share.
| Cash & Cash Equivalents | 732,000 |
| Total Debt | 2.27M |
| Net Cash | -1.54M |
| Net Cash Per Share | -$0.05 |
| Equity / Book Value | 18.57M |
| Book Value Per Share | 0.62 |
| Working Capital | 11.23M |
Cash Flow
In the last 12 months, operating cash flow was $283,486 and capital expenditures -$34,062, giving a free cash flow of $249,424.
| Operating Cash Flow | 283,486 |
| Capital Expenditures | -34,062 |
| Free Cash Flow | 249,424 |
| FCF Per Share | $0.01 |
Margins
Gross margin is 5.35%, with operating and profit margins of -1.09% and -0.62%.
| Gross Margin | 5.35% |
| Operating Margin | -1.09% |
| Pretax Margin | -0.59% |
| Profit Margin | -0.62% |
| EBITDA Margin | -0.12% |
| EBIT Margin | -1.08% |
| FCF Margin | 0.40% |
Dividends & Yields
INBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | -0.50% |
| Earnings Yield | -5.95% |
| FCF Yield | 3.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBP has an Altman Z-Score of 1.63 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 4 |